Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 14334 | 710 | 23.8 | 84% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | HCV CORE ANTIGEN | Author keyword | 33 | 74% | 4% | 25 |
| 2 | HCV CORE ANTIGEN ASSAY | Author keyword | 6 | 100% | 1% | 4 |
| 3 | HCV RNA STABILITY | Author keyword | 6 | 100% | 1% | 4 |
| 4 | HCV RNA | Author keyword | 5 | 11% | 7% | 48 |
| 5 | HEPATITIS C VIRUS CORE ANTIGEN | Author keyword | 4 | 56% | 1% | 5 |
| 6 | COBAS TAQMAN | Author keyword | 3 | 50% | 1% | 5 |
| 7 | ROUTINE DIAGNOSTIC LABORATORY | Author keyword | 3 | 50% | 1% | 5 |
| 8 | AUTOMATED RNA EXTRACTION | Author keyword | 3 | 100% | 0% | 3 |
| 9 | BDNA | Author keyword | 3 | 25% | 1% | 10 |
| 10 | HEPATITIS C CORE ANTIGEN | Author keyword | 3 | 60% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HCV CORE ANTIGEN | 33 | 74% | 4% | 25 | Search HCV+CORE+ANTIGEN | Search HCV+CORE+ANTIGEN |
| 2 | HCV CORE ANTIGEN ASSAY | 6 | 100% | 1% | 4 | Search HCV+CORE+ANTIGEN+ASSAY | Search HCV+CORE+ANTIGEN+ASSAY |
| 3 | HCV RNA STABILITY | 6 | 100% | 1% | 4 | Search HCV+RNA+STABILITY | Search HCV+RNA+STABILITY |
| 4 | HCV RNA | 5 | 11% | 7% | 48 | Search HCV+RNA | Search HCV+RNA |
| 5 | HEPATITIS C VIRUS CORE ANTIGEN | 4 | 56% | 1% | 5 | Search HEPATITIS+C+VIRUS+CORE+ANTIGEN | Search HEPATITIS+C+VIRUS+CORE+ANTIGEN |
| 6 | COBAS TAQMAN | 3 | 50% | 1% | 5 | Search COBAS+TAQMAN | Search COBAS+TAQMAN |
| 7 | ROUTINE DIAGNOSTIC LABORATORY | 3 | 50% | 1% | 5 | Search ROUTINE+DIAGNOSTIC+LABORATORY | Search ROUTINE+DIAGNOSTIC+LABORATORY |
| 8 | AUTOMATED RNA EXTRACTION | 3 | 100% | 0% | 3 | Search AUTOMATED+RNA+EXTRACTION | Search AUTOMATED+RNA+EXTRACTION |
| 9 | BDNA | 3 | 25% | 1% | 10 | Search BDNA | Search BDNA |
| 10 | HEPATITIS C CORE ANTIGEN | 3 | 60% | 0% | 3 | Search HEPATITIS+C+CORE+ANTIGEN | Search HEPATITIS+C+CORE+ANTIGEN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GENETICALLY DIVERSE PANEL | 31 | 92% | 2% | 12 |
| 2 | MONITOR V15 | 27 | 78% | 3% | 18 |
| 3 | VERSION 20 | 22 | 58% | 4% | 25 |
| 4 | WINDOW PHASE | 19 | 74% | 2% | 14 |
| 5 | AMPLIPREP COBAS TAQMAN HIV 1 | 18 | 89% | 1% | 8 |
| 6 | ABBOTT REALTIME | 17 | 72% | 2% | 13 |
| 7 | NAT ASSAYS | 16 | 64% | 2% | 16 |
| 8 | HCV RNA | 15 | 15% | 13% | 91 |
| 9 | NUCLISENS | 13 | 80% | 1% | 8 |
| 10 | VERSION 15 | 11 | 69% | 1% | 9 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Standardization of NAT for Blood-Borne Pathogens | 2015 | 1 | 32 | 38% |
| Systematic Review of the Performance of HIV Viral Load Technologies on Plasma Samples | 2014 | 7 | 44 | 70% |
| The potential role of HCV core antigen testing in diagnosing HCV infection | 2012 | 6 | 20 | 95% |
| Hepatitis C core Ag and its clinical applicability: Potential advantages and disadvantages for diagnosis and follow-up? | 2012 | 10 | 91 | 66% |
| Molecular diagnostics of hepatitis C virus infection - A systematic review | 2007 | 82 | 68 | 25% |
| Branched DNA technology in molecular diagnostics | 2006 | 25 | 19 | 58% |
| Comparison of the Abbott Realtime (TM) HIV-1 and HCV viral load assays with commercial competitor assays | 2008 | 10 | 37 | 51% |
| Virological tools to diagnose and monitor hepatitis C virus infection | 2011 | 32 | 32 | 16% |
| International Standards and Reference Materials for Quantitative Molecular Infectious Disease Testing | 2010 | 14 | 31 | 39% |
| Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products | 2001 | 41 | 10 | 40% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | UK NEQAS MICROBIOL | 2 | 67% | 0.3% | 2 |
| 2 | PROFESS HABITAT DESIGN | 1 | 100% | 0.3% | 2 |
| 3 | RICERCA AREA INFETTIVOL | 1 | 100% | 0.3% | 2 |
| 4 | REG BLOOD TRANSFUS COMPREHENS HAEMOPHILIA CARE | 1 | 40% | 0.3% | 2 |
| 5 | EQUIPE ACCUEIL 2656 | 1 | 33% | 0.3% | 2 |
| 6 | AISC | 1 | 50% | 0.1% | 1 |
| 7 | ARTIF LIVER | 1 | 50% | 0.1% | 1 |
| 8 | CHU SOURO SANOU | 1 | 50% | 0.1% | 1 |
| 9 | ER119 | 1 | 50% | 0.1% | 1 |
| 10 | INFECT DIS INT HEALTH | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000174656 | OCCULT HBV INFECTION//ANTI HBC//OCCULT HEPATITIS B VIRUS INFECTION |
| 2 | 0.0000154430 | CHRONIC HEPATITIS C//INTERFERON THERAPY//HCV RNA |
| 3 | 0.0000147249 | OCCULT HCV//OCCULT HEPATITIS C//OCCULT HCV INFECTION |
| 4 | 0.0000145370 | RIBA//ANTI HCV//NON A NON B HEPATITIS |
| 5 | 0.0000130279 | HCV GENOTYPES//INTERFERON SENSITIVITY DETERMINING REGION//HYPERVARIABLE REGION 1 |
| 6 | 0.0000130152 | PCR-METHODS AND APPLICATIONS//PLASMA VIREMIA//DIGOXIGENIN 11 DUTP |
| 7 | 0.0000107339 | TELAPREVIR//RIBAVIRIN//BOCEPREVIR |
| 8 | 0.0000092316 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1 SUBTYPES//CIRCULATING RECOMBINANT FORMS |
| 9 | 0.0000088966 | EARLY INFANT DIAGNOSIS//SINIKITHEMBA CLIN//INFANT DIAGNOSIS |
| 10 | 0.0000073266 | HIV LATENCY//HIV CURE//HIV 1 LATENCY |